These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26123874)

  • 1. Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.
    Imfeld P; Bodmer M; Jick SS; Meier CR
    Drug Saf; 2015 Oct; 38(10):909-19. PubMed ID: 26123874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.
    Imfeld P; Bodmer M; Jick SS; Meier CR
    Drug Saf; 2018 Dec; 41(12):1387-1396. PubMed ID: 30146658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data.
    Biétry FA; Pfeil AM; Reich O; Schwenkglenks M; Meier CR
    CNS Drugs; 2017 Mar; 31(3):245-251. PubMed ID: 28078633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza infections and risk of Alzheimer's disease.
    Imfeld P; Toovey S; Jick SS; Meier CR
    Brain Behav Immun; 2016 Oct; 57():187-192. PubMed ID: 27006278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study.
    Imfeld P; Bodmer M; Jick SS; Meier CR
    J Am Geriatr Soc; 2012 May; 60(5):916-21. PubMed ID: 22458300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.
    Happich M; Kirson NY; Desai U; King S; Birnbaum HG; Reed C; Belger M; Lenox-Smith A; Price D
    J Alzheimers Dis; 2016 May; 53(1):171-83. PubMed ID: 27163798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis.
    Imfeld P; Bodmer M; Schuerch M; Jick SS; Meier CR
    Epilepsia; 2013 Apr; 54(4):700-7. PubMed ID: 23215680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine use and risk of Alzheimer's disease: case-control study.
    Billioti de Gage S; Moride Y; Ducruet T; Kurth T; Verdoux H; Tournier M; Pariente A; Bégaud B
    BMJ; 2014 Sep; 349():g5205. PubMed ID: 25208536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK.
    Imfeld P; Brauchli Pernus YB; Jick SS; Meier CR
    J Alzheimers Dis; 2013; 35(3):565-73. PubMed ID: 23455986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study.
    Tapiainen V; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
    Acta Psychiatr Scand; 2018 Aug; 138(2):91-100. PubMed ID: 29851063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias.
    Davies NM; Kehoe PG; Ben-Shlomo Y; Martin RM
    J Alzheimers Dis; 2011; 26(4):699-708. PubMed ID: 21709373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Benzodiazepine Use Associated With the Risk of Dementia and Cognitive Impairment-Not Dementia in Older Persons? The Canadian Study of Health and Aging.
    Nafti M; Sirois C; Kröger E; Carmichael PH; Laurin D
    Ann Pharmacother; 2020 Mar; 54(3):219-225. PubMed ID: 31595772
    [No Abstract]   [Full Text] [Related]  

  • 13. Signal detection of benzodiazepine use and risk of dementia: sequence symmetry analysis using South Korean national healthcare database.
    Park KR; Kim KB; Baek YH; Sung HG; Park JT; Lee EK; Shin JY
    Int J Clin Pharm; 2018 Dec; 40(6):1568-1576. PubMed ID: 30367378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leisure activities, apolipoprotein E e4 status, and the risk of dementia.
    Yang SY; Weng PH; Chen JH; Chiou JM; Lew-Ting CY; Chen TF; Sun Y; Wen LL; Yip PK; Chu YM; Chen YC
    J Formos Med Assoc; 2015 Dec; 114(12):1216-24. PubMed ID: 25457293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of benzodiazepine discontinuation on dementia risk.
    Wu CS; Ting TT; Wang SC; Chang IS; Lin KM
    Am J Geriatr Psychiatry; 2011 Feb; 19(2):151-9. PubMed ID: 20808131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of anti-inflammatory drug use and risk of dementia: a matched case-control study.
    Dregan A; Chowienczyk P; Armstrong D
    Eur J Neurol; 2015 Nov; 22(11):1421-8. PubMed ID: 26177125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.
    Gray SL; Dublin S; Yu O; Walker R; Anderson M; Hubbard RA; Crane PK; Larson EB
    BMJ; 2016 Feb; 352():i90. PubMed ID: 26837813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of incident stroke in patients with Alzheimer disease or vascular dementia.
    Imfeld P; Bodmer M; Schuerch M; Jick SS; Meier CR
    Neurology; 2013 Sep; 81(10):910-9. PubMed ID: 23902701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data.
    Wu CS; Wang SC; Chang IS; Lin KM
    Am J Geriatr Psychiatry; 2009 Jul; 17(7):614-20. PubMed ID: 19546656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities in patients with vascular dementia and Alzheimer's disease with Neuropsychiatric symptoms.
    Gainey M; Niles A; Imeh-Nathaniel S; Goodwin RL; Roley LT; Win O; Nathaniel TI; Imeh-Nathaniel A
    Geriatr Nurs; 2024; 57():217-223. PubMed ID: 38696879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.